FDA says it will not authorize a second booster dose of the original COVID-19 mRNA vaccines for people ages 18 to 49 and will instead focus this fall on pushing out booster shots that target the BA.4 and BA.5 Omicron subvariants, an agency spokesperson told Inside Health Policy . The updated booster shots from Pfizer and Moderna should be ready by September, the spokesperson said. The BA.4/5 mRNA booster shots will be part of the fall vaccination campaigns and help...